PiCCO Guided Therapy in Liver Cirrhosis
Not Applicable
Completed
- Conditions
- Liver Cirrhosis
- Registration Number
- NCT00232427
- Lead Sponsor
- Heidelberg University
- Brief Summary
Prospective comparison of standard therapy in liver cirrhosis versus standard therapy plus intensified hemodynamic monitoring using the PiCCO system.
- Detailed Description
Patients presenting with advanced liver cirrhosis will receive either standard treatment or standard treatment plus hemodynamic monitoring with the PiCCO device. Fluids and vasoacitve drugs will be administered according to the measurements over a period of 5 days.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
- Liver cirrhosis Child-Pugh-Score > 7
- Ascites > 500 ml
Exclusion Criteria
- Coronary heart disease
- Apoplexia < 6 months ago
- Vasculitis
- Thrombosis
- Arterial occlusive disease > stadium II
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Survival
- Secondary Outcome Measures
Name Time Method Renal complications Length of intensive care Change in APACHE II
Trial Locations
- Locations (1)
University of Heidelberg, Clinical center
🇩🇪Heidelberg, Germany
University of Heidelberg, Clinical center🇩🇪Heidelberg, Germany